Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B cell-based therapy produces antibodies that inhibit glioblastoma growth.
Wang S, Castro BA, Katz JL, Arrieta V, Najem H, Vazquez-Cervantes GI, Wan H, Olson IE, Hou D, Dapash M, Billingham LK, Chia TY, Wei C, Rashidi A, Platanias LC, McCortney K, Horbinski CM, Stupp R, Zhang P, Ahmed AU, Sonabend AM, Heimberger AB, Lesniak MS, Riviere-Cazaux C, Burns T, Miska J, Fischietti M, Lee-Chang C. Wang S, et al. Among authors: heimberger ab. J Clin Invest. 2024 Aug 29;134(20):e177384. doi: 10.1172/JCI177384. J Clin Invest. 2024. PMID: 39207859 Free PMC article.
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J, Petrosyan E, Kanojia D, Dmello C, Cordero A, Duffy JT, Yeeravalli R, Sahani MH, Zhang P, Rashidi A, Arrieta VA, Ulasov I, Ahmed AU, Miska J, Balyasnikova IV, James CD, Sonabend AM, Heimberger AB, Lesniak MS. Fares J, et al. Among authors: heimberger ab. J Clin Invest. 2023 Dec 15;133(24):e161142. doi: 10.1172/JCI161142. J Clin Invest. 2023. PMID: 37847564 Free PMC article.
Antigen-presenting B cells promote TCF-1+ PD1- stem-like CD8+ T-cell proliferation in glioblastoma.
Hou D, Wan H, Katz JL, Wang S, Castro BA, Vazquez-Cervantes GI, Arrieta VA, Dhiantravan S, Najem H, Rashidi A, Chia TY, Arjmandi T, Collado J, Billingham L, Lopez-Rosas A, Han Y, Sonabend AM, Heimberger AB, Zhang P, Miska J, Lee-Chang C. Hou D, et al. Among authors: heimberger ab. Front Immunol. 2024 Jan 10;14:1295218. doi: 10.3389/fimmu.2023.1295218. eCollection 2023. Front Immunol. 2024. PMID: 38268923 Free PMC article.
Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas.
Tripathi S, Najem H, Dussold C, Pacheco S, Miska J, McCortney K, Steffens A, Walshon J, Winkowski D, Cloney M, Ordon M, Gibson W, Kemeny H, Youngblood M, Du R, Mossner J, Texakalidis P, Sprau A, Tate M, James CD, Horbinski CM, Wadhwani NR, Lesniak MS, Lam S, Sati A, Aghi M, DeCuypere M, Heimberger AB. Tripathi S, et al. Among authors: heimberger ab. J Clin Invest. 2024 Feb 15;134(4):e176613. doi: 10.1172/JCI176613. J Clin Invest. 2024. PMID: 38357919 Free PMC article. No abstract available.
Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors.
Drumm MR, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb B, Byrne K, Unruh D, Thirunavu V, Walshon J, Steffens A, McCortney K, Lukas RV, Phillips JJ, Mohamed E, Finan JD, Santana-Santos L, Heimberger AB, Franz CK, Kurz J, Templer JW, Swanson GT, Horbinski C. Drumm MR, et al. Among authors: heimberger ab. J Clin Invest. 2023 Jun 15;133(12):e168035. doi: 10.1172/JCI168035. J Clin Invest. 2023. PMID: 37104042 Free PMC article.
Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease.
Najem H, Arrieta VA, Duffy J, Tripathi S, Zannikou M, Dhiantravan S, Miska J, McCortney K, Steffens A, Walshon J, Lee Chang C, Dahdaleh NS, Sonabend AM, Smith Z, Horbinski CM, Chandler J, Heimberger AB, Balyasnikova IV. Najem H, et al. Among authors: heimberger ab. Ann Case Rep. 2024;9(1):1607. doi: 10.29011/2574-7754.101607. Epub 2024 Jan 25. Ann Case Rep. 2024. PMID: 38606301 Free PMC article.
SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression.
Fischietti M, Eckerdt F, Perez RE, Guillen Magaña JN, Mazewski C, Ho S, Gonzalez C, Streich LD, Beauchamp EM, Heimberger AB, Baran AH, Yue F, James CD, Platanias LC. Fischietti M, et al. Among authors: heimberger ab. Cancer Res Commun. 2022 Sep;2(9):966-978. doi: 10.1158/2767-9764.crc-22-0192. Epub 2022 Sep 13. Cancer Res Commun. 2022. PMID: 36382088 Free PMC article.
244 results